above and beyond which would otherwise be present due to sepsis alone. Given the significant clinical impact of AKI on mortality in sepsis, how many patients, in turn, die as a result of the same "benign" intervention?
In a recent comprehensive review, Myburgh and Mythen (7) suggest that a definitive randomized, controlled trial examining the safety and efficacy of normal saline compared with a balance salt solution is warranted. In light of the current study by Zhou et al (8) and accumulating evidence over the last decade, we could not agree more. C oncerns about pulmonary complications of positive pressure ventilation (1) are at least as old as the description of the acute respiratory distress syndrome (ARDS) (2). Yet, it took about a decade until experimental findings (3) shifted the focus from air leaks and oxygen toxicity to the biological effects of large excursions of the lung parenchyma (4). The demonstration that mechanical ventilation with high peak inspiratory pressures and low positive end-expiratory pressure (PEEP) could produce edema, increased alveolocapillary permeability, leukocyte infiltration, and inflammation in normal lungs established the current understanding of ventilatorinduced lung injury (VILI) (4, 5) . The clinical relevance of VILI was confirmed by the demonstration of a 22% decrease in mortality of ARDS patients when lung stretch was reduced through lower tidal volumes (V T ) (6) . In addition to excessive lung stretch due to large V T , it has been recognized that VILI can also be caused by low end-expiratory lung volumes, even at low airway pressures. Mechanisms proposed to explain such injury include concentration of stresses in the heterogeneously expanding lung parenchyma (7) and propagation and rupture of liquid plugs producing injurious fluid mechanical stresses during cyclic recruitment-derecruitment of distal lung units (8, 9) . Mitigation of these low-volume phenomena by optimizing lung recruitment with higher PEEP levels (10) and proning (11) has been beneficial in patients with moderate and severe ARDS. However, despite the large number of experimental and clinical studies, uncertainty persists about Lung Metabolism During Ventilator-Induced Lung Injury: Stretching the Relevance of the Normally Aerated Lung* the relative contribution of overdistension versus low-volume injury to the ultimate lung damage produced by VILI (12) . Topographically, in supine patients, nondependent (ventral) injury would be expected if overdistension would predominate (13) , whereas dependent (dorsal) damage would be expected for predominant low-volume injury (14) . The clinical relevance of the topic has been emphasized by the suggestion that the mass of opening-closing lung is an independent risk factor for death in patients with ARDS (15) and that regional forces during mechanical ventilation determine lung parenchyma abnormalities found in ARDS survivors (16) .
In this setting, there is growing interest on the application of PET with 18-F-fluorodeoxyglucose ( 18 F-FDG) as a noninvasive in vivo tool to measure global and regional lung metabolism during lung injury indicative of lung inflammation (17, 18) . Previous experimental studies have shown that lung 18 F-FDG uptake is a sensitive biomarker of lung neutrophilic accumulation and activity during VILI (14, 19, 20) . In this issue of Critical Care Medicine, Borges et al (21) use 18 F-FDG PET to locate and quantify lung inflammation in a two-hit porcine model of ARDS (severe surfactant depletion + injurious mechanical ventilation). Consistent with observations in supine patients, the model yielded topographically heterogeneous lung inflation with nondependent tidal hyperinflation and dependent cyclic recruitment together with complete derecruitment. Surprisingly, these most nondependent and dependent regions did not exhibit significant larger 18 F-FDG uptake than corresponding regions in control animals despite plateau pressures of 44 cm H 2 O. Instead, increases in 18 F-FDG uptake occurred more evidently in regions of normal and poor aeration located at intermediate vertical distances. This lead Borges et al (21) to theorize that tidal stretch, not overdistension or cyclic recruitment-derecruitment, is the main mechanical determinant of VILI in those severe experimental conditions. The higher regional compliance in normally and poorly aerated regions would determine their increased ventilation and large tidal stretch igniting lung inflammation. Hyperinflated and nonaerated regions would have the indirect relevance of diverting ventilation to those areas of higher compliance. Importantly, the authors addressed the effect of heterogeneous lung density indicating it was unlikely that the observed differences in regional 18 F-FDG uptake were solely due to local density changes.
This clinically relevant large animal study invites several considerations. Given that the presumed injurious factors such as regional strain (or regional ventilation as a surrogate of strain) were not measured, a definite statement could not be made on the causes of the increased regional lung metabolism. Interestingly, the findings by Borges et al (21) appear to contradict a previous unilateral surfactant depletion (saline lavage) study where regional ventilation was measured and found to be higher in normal (nonlavaged) than in surfactant-depleted lung regions. 18 F-FDG-uptake in that study was still higher in low ventilation surfactant-depleted regions (14) . This suggests that in the study by Borges et al (21) , either the combination of tidal stretch and surfactant depletion lead to increased regional 18 F-FDG uptake or the redistribution of regional aeration resulted in regional tidal strains substantially larger than those observed with that unilateral injury. PET images were acquired only at the end of experiment following three interventions: alveolar lavage, 210 minutes of high V T (20 mL/kg) and low PEEP (4 cm H 2 O), and 4 hours of less high V T (15 mL/kg) and high PEEP (15 cm H 2 O). As such, the specific mechanisms producing the regional metabolic changes await identification. It is conceivable that nonaerated and/or cyclically recruited regions during the low PEEP-high V T phase could have been recruited during the higher PEEPlower V T phase and at least partially contributed to findings assigned to normal or poorly aerated regions. However, the minimal change in compliance between those phases suggests minimal lung recruitment. The specific tissue determinants of the increased lung metabolism will also need to be identified (17, 20, 22, 23) . The data from Borges et al (21) show intriguing trends for increases in 18 F-FDG uptake both in nonaerated and hyperinflated regions, which might not have reached consistent statistical significance due to the small number of animals. In this case, their findings would point to the multifactorial nature of regional metabolic activation during severe injury, including factors such as heterogeneities in lung parenchymal impedances underlying the imaging resolution (24) . Finally, given the deliberately exaggerated ventilatory settings used in this physiological study, the topographical findings need to be translated to clinical scenarios with great care.
In conclusion, Borges et al (21) alert us that the safety of aerated lung regions cannot be taken for granted during mechanical ventilation, even when their CT appearance suggests normality. Ventilatory strategies should not only avoid overdistension and derecruitment but also prevent excessive stretch and inflammation of the normally and poorly aerated lung. L ipoxins (lipoxygenase interaction products) are not a recent discovery; they have been on the block since 1984 when they were first characterized by Serhan et al (1) . Lipoxins are derivatives of arachidonic acid, and their synthesis in disease conditions primarily relies on transcellular metabolism between polymorphonuclear neutrophils and platelets, generating two main species: lipoxin (LX) A 4 and LXB 4 (2). One of the endo genous lipoxin epimers termed the "aspirin-triggered 15-epi-LXA 4 " has attracted considerable interest given that it has been identified as the first natural mediator of the arachidonic acid pathway to promote resolution and to possess very potent and broad anti-inflammatory rather than proinflammatory properties (3). Benefits of LXA 4 and 15-epi-LXA 4 have been well demonstrated in various animal models of both chronic (e.g., asthma and dermatitis) and acute inflammatory conditions (e.g., pancreatitis, lung injury, and ischemia reperfusion injury) when administered systemically (4), intratracheally (5), and/or topically (6) . Although lipoxins have not been yet therapeutically tested in patients, the promising preclinical data have provoked a number of observational human trials in diabetes (at http://www.clinicaltrials.gov; NCT01040819, completed), asthma (NCT01761630, recruiting; NCT01898767, just launched), and cystic fibrosis (NCT01883284, recruiting).
The article by Ueda et al (7) in this issue of Critical Care Medicine tackles yet another type of violent inflammation-based condition: sepsis. Although, when compared with the late 1980s, the improvement of modern critical care protocols has helped to generate an approximate 25% decrease in sepsis deaths (8) , the overall mortality remains unacceptably high and the number of
